Displaying drugs 226 - 250 of 338 in total
Halofuginone
Halofuginone is a low molecular weight quinazolinone alkaloid, and a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression. Halofuginone also effectively suppresses tumor progression and metastasis in mice. Collgard Biopharmaceuticals is developing halofuginone for the treatment of scleroderma and received orphan drug designation from the U.S....
Investigational
Vet approved
CRS-3123
CRS3123 has been used in trials studying the treatment of Clostridial Infection and Clostridium Difficile Colitis.
Investigational
(S)-wiskostatin
Experimental
6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone
Experimental
5-Bromothienyldeoxyuridine
Experimental
6-bromoindirubin-3'-oxime
Experimental
Sulfabromomethazine
Vet approved
Sorivudine
Sorivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.
Investigational
Haloxazolam
Experimental
Illicit
R048-8071
Experimental
Bromo-Willardiine
Experimental
Bromo-WR99210
Experimental
5-Bromoindirubin
Experimental
Crolibulin
Crolibulin has been used in trials studying the treatment of Solid Tumor and Anaplastic Thyroid Cancer.
Investigational
4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN
Experimental
(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE
Experimental
Displaying drugs 226 - 250 of 338 in total